{"id":149928,"date":"2020-05-26T16:01:28","date_gmt":"2020-05-26T16:01:28","guid":{"rendered":"https:\/\/www.bnreport.com\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\/"},"modified":"2020-05-26T16:01:28","modified_gmt":"2020-05-26T16:01:28","slug":"gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2","status":"publish","type":"post","link":"https:\/\/www.bnreport.com\/en\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\/","title":{"rendered":"Gilead Sciences\u2019 remdesivir to be available for selected Covid-19 patients in the UK"},"content":{"rendered":"

Gilead Sciences Incs (NASDAQ:GILD<\/a>) remdesivir will de administered to selected Covid-19 patients in the UK.<\/p>\n

The Medicines and Healthcare Products Regulatory Agency granted on Tuesday temporary access to the drug, which is not approved in any country.<\/p>\n

READ: Gilead Sciences' remdesivir to be distributed in 127 countries<\/a>[hhmc]
\n<\/h4>\n

The government said that treatment will be prioritised for patients likely to benefit the most due to limited supplies.<\/p>\n

Remdesivir is currently being used in the US and in Japan as an emergency treatment, while Gilead agreed licensing agreements with five generic pharmaceutical manufacturers to supply in 127 countries earlier this month.<\/p>\n

Read More \u2013 Source<\/a>
\n[contf]
\n[contfnew]
\n <\/p>\n

Proactiveinvestors<\/a><\/h5>\n

[contfnewc]
\n[contfnewc]<\/p>\n","protected":false},"excerpt":{"rendered":"

Gilead Sciences Incs (NASDAQ:GILD) remdesivir will de administered to selected Covid-19 patients in ..<\/p>\n","protected":false},"author":1,"featured_media":149929,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[46],"tags":[],"class_list":["post-149928","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-politics"],"yoast_head":"\nGilead Sciences\u2019 remdesivir to be available for selected Covid-19 patients in the UK - Business News Report<\/title>\n<meta name=\"description\" content=\"Gilead Sciences Incs (NASDAQ:GILD) remdesivir will de administered to selected Covid-19 patients in ..\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.bnreport.com\/en\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gilead Sciences\u2019 remdesivir to be available for selected Covid-19 patients in the UK - Business News Report\" \/>\n<meta property=\"og:description\" content=\"Gilead Sciences Incs (NASDAQ:GILD) remdesivir will de administered to selected Covid-19 patients in ..\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.bnreport.com\/en\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Business News Report\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Business-NewsReport-328225811095934\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-05-26T16:01:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/05\/1590495703_2020-05-26-13-21-43_4ee0425ec4d916f97c0572281286fd86-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"916\" \/>\n\t<meta property=\"og:image:height\" content=\"423\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"infopal11\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@BNReport\" \/>\n<meta name=\"twitter:site\" content=\"@BNReport\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"infopal11\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\\\/\"},\"author\":{\"name\":\"infopal11\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/person\\\/19d1c5a2dd7f60584a09de4a7805d68f\"},\"headline\":\"Gilead Sciences\u2019 remdesivir to be available for selected Covid-19 patients in the UK\",\"datePublished\":\"2020-05-26T16:01:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\\\/\"},\"wordCount\":120,\"publisher\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/1590495703_2020-05-26-13-21-43_4ee0425ec4d916f97c0572281286fd86-1.jpg\",\"articleSection\":[\"Politics\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\\\/\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\\\/\",\"name\":\"Gilead Sciences\u2019 remdesivir to be available for selected Covid-19 patients in the UK - Business News Report\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/1590495703_2020-05-26-13-21-43_4ee0425ec4d916f97c0572281286fd86-1.jpg\",\"datePublished\":\"2020-05-26T16:01:28+00:00\",\"description\":\"Gilead Sciences Incs (NASDAQ:GILD) remdesivir will de administered to selected Covid-19 patients in ..\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.bnreport.com\\\/en\\\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/1590495703_2020-05-26-13-21-43_4ee0425ec4d916f97c0572281286fd86-1.jpg\",\"contentUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/05\\\/1590495703_2020-05-26-13-21-43_4ee0425ec4d916f97c0572281286fd86-1.jpg\",\"width\":916,\"height\":423},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629\",\"item\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gilead Sciences\u2019 remdesivir to be available for selected Covid-19 patients in the UK\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/\",\"name\":\"Business News Report\",\"description\":\"Latest News on the World of Politics & Business\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#organization\",\"name\":\"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/LOGO2.png\",\"contentUrl\":\"https:\\\/\\\/www.bnreport.com\\\/wp-content\\\/uploads\\\/2020\\\/12\\\/LOGO2.png\",\"width\":200,\"height\":50,\"caption\":\"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a\"},\"image\":{\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Business-NewsReport-328225811095934\\\/\",\"https:\\\/\\\/x.com\\\/BNReport\",\"https:\\\/\\\/www.instagram.com\\\/business.newsreport\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/#\\\/schema\\\/person\\\/19d1c5a2dd7f60584a09de4a7805d68f\",\"name\":\"infopal11\",\"url\":\"https:\\\/\\\/www.bnreport.com\\\/en\\\/author\\\/infopal11\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gilead Sciences\u2019 remdesivir to be available for selected Covid-19 patients in the UK - Business News Report","description":"Gilead Sciences Incs (NASDAQ:GILD) remdesivir will de administered to selected Covid-19 patients in ..","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.bnreport.com\/en\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\/","og_locale":"en_US","og_type":"article","og_title":"Gilead Sciences\u2019 remdesivir to be available for selected Covid-19 patients in the UK - Business News Report","og_description":"Gilead Sciences Incs (NASDAQ:GILD) remdesivir will de administered to selected Covid-19 patients in ..","og_url":"https:\/\/www.bnreport.com\/en\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\/","og_site_name":"Business News Report","article_publisher":"https:\/\/www.facebook.com\/Business-NewsReport-328225811095934\/","article_published_time":"2020-05-26T16:01:28+00:00","og_image":[{"width":916,"height":423,"url":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/05\/1590495703_2020-05-26-13-21-43_4ee0425ec4d916f97c0572281286fd86-1.jpg","type":"image\/jpeg"}],"author":"infopal11","twitter_card":"summary_large_image","twitter_creator":"@BNReport","twitter_site":"@BNReport","twitter_misc":{"Written by":"infopal11","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.bnreport.com\/en\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\/#article","isPartOf":{"@id":"https:\/\/www.bnreport.com\/en\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\/"},"author":{"name":"infopal11","@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/person\/19d1c5a2dd7f60584a09de4a7805d68f"},"headline":"Gilead Sciences\u2019 remdesivir to be available for selected Covid-19 patients in the UK","datePublished":"2020-05-26T16:01:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.bnreport.com\/en\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\/"},"wordCount":120,"publisher":{"@id":"https:\/\/www.bnreport.com\/en\/#organization"},"image":{"@id":"https:\/\/www.bnreport.com\/en\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/05\/1590495703_2020-05-26-13-21-43_4ee0425ec4d916f97c0572281286fd86-1.jpg","articleSection":["Politics"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.bnreport.com\/en\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\/","url":"https:\/\/www.bnreport.com\/en\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\/","name":"Gilead Sciences\u2019 remdesivir to be available for selected Covid-19 patients in the UK - Business News Report","isPartOf":{"@id":"https:\/\/www.bnreport.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.bnreport.com\/en\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\/#primaryimage"},"image":{"@id":"https:\/\/www.bnreport.com\/en\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/05\/1590495703_2020-05-26-13-21-43_4ee0425ec4d916f97c0572281286fd86-1.jpg","datePublished":"2020-05-26T16:01:28+00:00","description":"Gilead Sciences Incs (NASDAQ:GILD) remdesivir will de administered to selected Covid-19 patients in ..","breadcrumb":{"@id":"https:\/\/www.bnreport.com\/en\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.bnreport.com\/en\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.bnreport.com\/en\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\/#primaryimage","url":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/05\/1590495703_2020-05-26-13-21-43_4ee0425ec4d916f97c0572281286fd86-1.jpg","contentUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/05\/1590495703_2020-05-26-13-21-43_4ee0425ec4d916f97c0572281286fd86-1.jpg","width":916,"height":423},{"@type":"BreadcrumbList","@id":"https:\/\/www.bnreport.com\/en\/gilead-sciences-remdesivir-to-be-available-for-selected-covid-19-patients-in-the-uk-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u0627\u0644\u0631\u0626\u064a\u0633\u064a\u0629","item":"https:\/\/www.bnreport.com\/en\/"},{"@type":"ListItem","position":2,"name":"Gilead Sciences\u2019 remdesivir to be available for selected Covid-19 patients in the UK"}]},{"@type":"WebSite","@id":"https:\/\/www.bnreport.com\/en\/#website","url":"https:\/\/www.bnreport.com\/en\/","name":"Business News Report","description":"Latest News on the World of Politics & Business","publisher":{"@id":"https:\/\/www.bnreport.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.bnreport.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.bnreport.com\/en\/#organization","name":"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a","url":"https:\/\/www.bnreport.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/12\/LOGO2.png","contentUrl":"https:\/\/www.bnreport.com\/wp-content\/uploads\/2020\/12\/LOGO2.png","width":200,"height":50,"caption":"\u0628\u0632\u0646\u0633 \u0631\u064a\u0628\u0648\u0631\u062a \u0627\u0644\u0627\u062e\u0628\u0627\u0631\u064a"},"image":{"@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Business-NewsReport-328225811095934\/","https:\/\/x.com\/BNReport","https:\/\/www.instagram.com\/business.newsreport"]},{"@type":"Person","@id":"https:\/\/www.bnreport.com\/en\/#\/schema\/person\/19d1c5a2dd7f60584a09de4a7805d68f","name":"infopal11","url":"https:\/\/www.bnreport.com\/en\/author\/infopal11\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/posts\/149928","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/comments?post=149928"}],"version-history":[{"count":0,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/posts\/149928\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/media\/149929"}],"wp:attachment":[{"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/media?parent=149928"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/categories?post=149928"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bnreport.com\/en\/wp-json\/wp\/v2\/tags?post=149928"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}